About Our Company
65Bio is a biotech company dedicated to the acquisition, research, development and commercialization of pharmacological therapies for debilitating diseases. Its lead pre-clinical product, 6B-001, is targeting auditory disorders, an area of significant unmet medical need. The company's founders and senior management have an extensive track record of building successful biotech companies and developing innovative therapies.